FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:FME - DE0005785802 - Common Stock
40.64 EUR
+1.14 (+2.89%)
Overall FME gets a fundamental rating of 5 out of 10. We evaluated FME against 32 industry peers in the Health Care Providers & Services industry. FME has an average financial health and profitability rating. FME is valued quite cheap, while showing a decent growth score. This is a good combination! FME also has an excellent dividend rating. These ratings would make FME suitable for value and dividend investing!
1. Profitability
1.1 Basic Checks
In the past year FME was profitable.
FME had a positive operating cash flow in the past year.
In the past 5 years FME has always been profitable.
Each year in the past 5 years FME had a positive operating cash flow.
1.2 Ratios
FME has a Return On Assets (2.33%) which is in line with its industry peers.
The Return On Equity of FME (5.55%) is comparable to the rest of the industry.
FME has a Return On Invested Capital (3.95%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for FME is below the industry average of 7.02%.
The 3 year average ROIC (3.14%) for FME is below the current ROIC(3.95%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
Looking at the Profit Margin, with a value of 3.66%, FME is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
In the last couple of years the Profit Margin of FME has declined.
FME has a Operating Margin of 7.19%. This is in the better half of the industry: FME outperforms 68.75% of its industry peers.
FME's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 25.00%, FME is doing good in the industry, outperforming 65.63% of the companies in the same industry.
FME's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
FME has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
FME has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for FME has been reduced compared to 5 years ago.
The debt/assets ratio for FME has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.20 indicates that FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of FME (2.20) is comparable to the rest of the industry.
The Debt to FCF ratio of FME is 5.97, which is a neutral value as it means it would take FME, 5.97 years of fcf income to pay off all of its debts.
FME's Debt to FCF ratio of 5.97 is fine compared to the rest of the industry. FME outperforms 68.75% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that FME is somewhat dependend on debt financing.
FME's Debt to Equity ratio of 0.73 is fine compared to the rest of the industry. FME outperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 2.2 |
ROIC/WACC0.7
WACC5.68%
2.3 Liquidity
FME has a Current Ratio of 1.36. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.36, FME is doing good in the industry, outperforming 71.88% of the companies in the same industry.
FME has a Quick Ratio of 1.36. This is a bad value and indicates that FME is not financially healthy enough and could expect problems in meeting its short term obligations.
FME's Quick ratio of 1.00 is fine compared to the rest of the industry. FME outperforms 65.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.77%, which is quite good.
Measured over the past years, FME shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.43% on average per year.
FME shows a small growth in Revenue. In the last year, the Revenue has grown by 2.10%.
FME shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.04% yearly.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
The Earnings Per Share is expected to grow by 12.37% on average over the next years. This is quite good.
FME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.81% yearly.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.37%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.81%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.81, the valuation of FME can be described as reasonable.
Based on the Price/Earnings ratio, FME is valued cheaply inside the industry as 90.63% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.25, FME is valued rather cheaply.
The Price/Forward Earnings ratio is 9.80, which indicates a very decent valuation of FME.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FME indicates a rather cheap valuation: FME is cheaper than 90.63% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of FME to the average of the S&P500 Index (23.98), we can say FME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.81 | ||
| Fwd PE | 9.8 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FME is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, FME is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.59 | ||
| EV/EBITDA | 10.57 |
4.3 Compensation for Growth
FME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FME's earnings are expected to grow with 13.16% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.69%, FME has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.57, FME pays a better dividend. On top of this FME pays more dividend than 96.88% of the companies listed in the same industry.
FME's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.69% |
5.2 History
The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
58.83% of the earnings are spent on dividend by FME. This is a bit on the high side, but may be sustainable.
The dividend of FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
FRA:FME (1/12/2026, 7:00:00 PM)
40.64
+1.14 (+2.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.91%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.85B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts57.86
Price Target47.6 (17.13%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.69% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-0.53%
PT rev (3m)-5.45%
EPS NQ rev (1m)2.82%
EPS NQ rev (3m)-3.65%
EPS NY rev (1m)0.17%
EPS NY rev (3m)3.37%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)1.16%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.81 | ||
| Fwd PE | 9.8 | ||
| P/S | 1.21 | ||
| P/FCF | 13.59 | ||
| P/OCF | 9.5 | ||
| P/B | 1.84 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.57 |
EPS(TTM)3.76
EY9.25%
EPS(NY)4.15
Fwd EY10.2%
FCF(TTM)2.99
FCFY7.36%
OCF(TTM)4.28
OCFY10.53%
SpS33.47
BVpS22.07
TBVpS-3.21
PEG (NY)0.5
PEG (5Y)N/A
Graham Number43.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.2 |
F-Score5
WACC5.68%
ROIC/WACC0.7
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.37%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.81%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.22%
EBIT Next 3Y29.78%
EBIT Next 5Y18.33%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status for FME stock?
ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Undervalued.
Can you provide the profitability details for FRESENIUS MEDICAL CARE AG?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 5 / 10.
What is the valuation of FRESENIUS MEDICAL CARE AG based on its PE and PB ratios?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 10.81 and the Price/Book (PB) ratio is 1.84.
How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 58.83%.